Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: Very High
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
49,134
Total Claims
$3.5M
Drug Cost
735
Beneficiaries
$4,753
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-30%
Opioid rate vs peers
1.8% vs 2.6% avg
+284%
Cost per patient vs peers
$4,753 vs $1,237 avg
+41%
Brand preference vs peers
12.9% vs 9.2% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.8%
Opioid Rate
882
Opioid Claims
$15K
Opioid Cost
1.2%
Long-Acting Rate
Brand vs Generic
Brand: 6,325 claims · $2.4M
Generic: 42,709 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,378 | $374K |
| Deutetrabenazine | 98 | $221K |
| Valbenazine Tosylate | 63 | $199K |
| Paliperidone Palmitate | 57 | $185K |
| Pimavanserin Tartrate | 49 | $112K |
| Aripiprazole | 33 | $84K |
| Risperidone Microspheres | 81 | $79K |
| Bictegrav/Emtricit/Tenofov Ala | 19 | $76K |
| Rifaximin | 35 | $65K |
| Divalproex Sodium | 1,263 | $61K |
| Rivaroxaban | 184 | $55K |
| Dulaglutide | 78 | $52K |
| Dextromethorphan Hbr/Quinidine | 76 | $50K |
| Insulin Glargine,hum.Rec.Anlog | 186 | $46K |
| Atorvastatin Calcium | 3,297 | $44K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
3.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About